July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Altered glial response in a tenascin-C deficient autoimmune glaucoma mouse model
Author Affiliations & Notes
  • Susanne Wiemann
    Cell Morphology and Molecular Neurobiology, Ruhr-University Bochum, Germany
  • Jacqueline Reinhard
    Cell Morphology and Molecular Neurobiology, Ruhr-University Bochum, Germany
  • Sabrina Reinehr
    Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Germany
  • Zülal Cibir
    Cell Morphology and Molecular Neurobiology, Ruhr-University Bochum, Germany
  • Stephanie C Joachim
    Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Germany
  • Andreas Faissner
    Cell Morphology and Molecular Neurobiology, Ruhr-University Bochum, Germany
  • Footnotes
    Commercial Relationships   Susanne Wiemann, None; Jacqueline Reinhard, None; Sabrina Reinehr, None; Zülal Cibir, None; Stephanie Joachim, None; Andreas Faissner, None
  • Footnotes
    Support  Konrad-Adenauer-Foundation (200520593)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4391. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Susanne Wiemann, Jacqueline Reinhard, Sabrina Reinehr, Zülal Cibir, Stephanie C Joachim, Andreas Faissner; Altered glial response in a tenascin-C deficient autoimmune glaucoma mouse model. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4391.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The molecular mechanisms of glaucomatous retinal ganglion cell (RGC) and optic nerve degeneration are not fully understood. The extracellular matrix protein tenascin-C (TNC) is a modulator of the immune response and triggers inflammation. In this study, we used an experimental autoimmune glaucoma mouse model to analyze the role of TNC on glial responses during retinal und optic nerve degeneration. Therefore, TNC knockout (KO) mice were compared to wild type (WT) animals.

Methods : WT (WT ONA) and KO (KO ONA) mice (6 weeks, both sexes) were immunized with an optic nerve antigen homogenate, Freund`s adjuvant and pertussis toxin. Booster injections were given after 4 and 8 weeks. Control groups (CO) obtained sodium chloride (WT CO; KO CO). 10 weeks after immunization, we quantified the number of Brn3a+ RGCs in retinal flat-mounts (n=8/group), immunoreactivity of GFAP+ astrocytes in retina (n=8/group) and optic nerve sections (n=5/group). In addition, we investigated oligodendroglia with the markers oligodendrocyte transcription factor 2 (Olig2) and the myelin basic protein (MBP) in optic nerve sections (n=5/group). Groups were compared using one-way ANOVA followed by Tukey`s post hoc test.

Results : A significant reduction of Brn3a+ cells was detected in ONA-treated WT (p=0.0003) and KO (p=0.01) animals. GFAP immunoreactivity was significantly increased in retina (WT ONA: 9.01 area [%]/image; WT CO: 5.39 area [%]/image; p=0.01) and optic nerve sections (WT ONA: 24.31 area [%]/image; WT CO: 12.36 area [%]/image; p=0.04) of WT ONA compared to WT CO, whereas KO ONA showed no significant changes. Furthermore, a significant loss of Olig2+ cells (p=0.01) and MBP+ signal (p=0.02) was found in WT ONA in comparison to WT CO. Interestingly, no decrease of these oligodendrocyte markers could be detected in the KO ONA group.

Conclusions : This study showed RGC degeneration in WT and KO after immunization. The increased GFAP immunoreactivity and the reduction of oligodendrocyte marker expression is in line with the loss of RGC axons in WT ONA. In contrast, TNC deficiency resulted in a diminished glial reaction. These results indicate that TNC plays a significant role in the macroglial response during retinal und optic nerve degeneration.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×